COMPASS Pathways plc financial data

Symbol
CMPS on Nasdaq
Industry
Pharmaceutical Preparations
Location
3 Rd Floor, 1 Ashley Road, Altrincham, Chesire, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
Compass Rx Ltd. (to 8/10/2020)
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 979 % -36.4%
Debt-to-equity 25.9 % +38%
Return On Equity -74.5 % -26.8%
Return On Assets -59.2 % -19.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 92.7M shares +35.5%
Common Stock, Shares, Outstanding 68.6M shares +10.7%
Entity Public Float 355M USD +64.5%
Common Stock, Value, Issued 702K USD +10.6%
Weighted Average Number of Shares Outstanding, Basic 67.5M shares +32.2%
Weighted Average Number of Shares Outstanding, Diluted 67.5M shares +32.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 119M USD +36%
General and Administrative Expense 59.2M USD +19.8%
Operating Income (Loss) -178M USD -30.2%
Nonoperating Income (Expense) 24.7M USD +28.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -154M USD -30.5%
Income Tax Expense (Benefit) 1.59M USD +104%
Net Income (Loss) Attributable to Parent -155M USD -30.9%
Earnings Per Share, Basic -2.3 USD/shares +0.86%
Earnings Per Share, Diluted -2.3 USD/shares +0.86%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 165M USD -25%
Other Assets, Current 2.19M USD +15.6%
Assets, Current 201M USD -23%
Deferred Income Tax Assets, Net 3.77M USD +13.1%
Property, Plant and Equipment, Net 189K USD -55.3%
Operating Lease, Right-of-Use Asset 2.01M USD -53.4%
Other Assets, Noncurrent 6.6M USD -6.44%
Assets 214M USD -22.6%
Accounts Payable, Current 12.3M USD +108%
Employee-related Liabilities, Current 7.91M USD +12%
Liabilities, Current 34M USD +73.5%
Operating Lease, Liability, Noncurrent 303K USD -83.9%
Liabilities 59M USD +17.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -16.2M USD +4.33%
Retained Earnings (Accumulated Deficit) -535M USD -40.9%
Stockholders' Equity Attributable to Parent 155M USD -31.5%
Liabilities and Equity 214M USD -22.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.8M USD +24.9%
Net Cash Provided by (Used in) Financing Activities 63.5M USD +5786%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 68.6M shares +10.7%
Common Stock, Shares, Issued 68.6M shares +10.7%
Common Stock, Par or Stated Value Per Share 0.01 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 42.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 165M USD -25%
Interest Paid, Excluding Capitalized Interest, Operating Activities 765K USD
Deferred Tax Assets, Valuation Allowance 100M USD +31.6%
Deferred Tax Assets, Gross 104M USD +30.7%
Operating Lease, Liability 2.03M USD -52.8%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -154M USD -30.3%
Lessee, Operating Lease, Liability, to be Paid 2.12M USD -54.4%
Operating Lease, Liability, Current 1.73M USD -28.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 226K USD -87.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.8M USD -28.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 92K USD -74.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 94K USD -59%
Deferred Tax Assets, Operating Loss Carryforwards 84.9M USD +31.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 95K USD +75.9%
Operating Lease, Payments 628K USD +11.7%
Additional Paid in Capital 705M USD +13.4%
Depreciation, Depletion and Amortization 61K USD +27.1%
Share-based Payment Arrangement, Expense 19.5M USD +13%
Interest Expense 1.1M USD